Cargando…
Integrative Genomic Analyses of 1,145 Patient Samples Reveal New Biomarkers in Esophageal Squamous Cell Carcinoma
Due to the lack of effective diagnostic markers and therapeutic targets, esophageal squamous cell carcinoma (ESCC) shows a poor 5 years survival rate of less than 30%. To explore the potential therapeutic targets of ESCC, we integrated and reanalyzed the mutation data of WGS (whole genome sequencing...
Autores principales: | Zou, Binbin, Guo, Dinghe, Kong, Pengzhou, Wang, Yanqiang, Cheng, Xiaolong, Cui, Yongping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814608/ https://www.ncbi.nlm.nih.gov/pubmed/35127817 http://dx.doi.org/10.3389/fmolb.2021.792779 |
Ejemplares similares
-
CDCA7 Facilitates Tumor Progression by Directly Regulating CCNA2 Expression in Esophageal Squamous Cell Carcinoma
por: Li, Hongyi, et al.
Publicado: (2021) -
A Novel Ferroptosis-Related Biomarker Signature to Predict Overall Survival of Esophageal Squamous Cell Carcinoma
por: Song, Jiahang, et al.
Publicado: (2021) -
Metabolomic Characterization Reveals ILF2 and ILF3 Affected Metabolic Adaptions in Esophageal Squamous Cell Carcinoma
por: Zang, Bin, et al.
Publicado: (2021) -
The Role of DBR1 as a Candidate Prognosis Biomarker in Esophageal Squamous Cell Carcinoma
por: Xu, Xiaoqin, et al.
Publicado: (2022) -
Identification of the Prognostic Value of Tumor Microenvironment-Related Genes in Esophageal Squamous Cell Carcinoma
por: Zhang, Donglei, et al.
Publicado: (2020)